Á¦9Àå ¼¼°èÀÇ 3D ÇÁ¸°Æ® ÀǾàǰ ½ÃÀå ÆÇ¸Å ºÐ¼® : Áö¿ªº°
Áö¿ªº° Àü¸Á ÆÇ¸Å ºÐ¼®
¼·Ð ÆÇ¸Å ºÐ¼®
ºÏ¹ÌÀÇ ÆÇ¸Å ºÐ¼®
°³¿ä, ½ÇÀû°ú ¿¹Ãø
ºÏ¹Ì : ºÎ¹®º°
ºÏ¹Ì : ±¹°¡º°
¹Ì±¹
ij³ª´Ù
¸ß½ÃÄÚ
À¯·´ ÆÇ¸Å ºÐ¼®
°³¿ä, ½ÇÀû°ú ¿¹Ãø
À¯·´ : ºÎ¹®º°
À¯·´ : ±¹°¡º°
¿µ±¹
ÇÁ¶û½º
µ¶ÀÏ
ÀÌÅ»¸®¾Æ
·¯½Ã¾Æ
±âŸ À¯·´
¾Æ½Ã¾ÆÅÂÆò¾ç ÆÇ¸Å ºÐ¼®
°³¿ä, ½ÇÀû°ú ¿¹Ãø
¾Æ½Ã¾ÆÅÂÆò¾ç : ºÎ¹®º°
¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º°
Áß±¹
Àεµ
ÀϺ»
Çѱ¹
È£ÁÖ
±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
¶óƾ¾Æ¸Þ¸®Ä« ÆÇ¸Å ºÐ¼®
°³¿ä, ½ÇÀû°ú ¿¹Ãø
¶óƾ¾Æ¸Þ¸®Ä« : ºÎ¹®º°
¶óƾ¾Æ¸Þ¸®Ä« : ±¹°¡º°
ºê¶óÁú
¾Æ¸£ÇîÆ¼³ª
Æä·ç
Ä¥·¹
±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ÆÇ¸Å ºÐ¼®
°³¿ä, ½ÇÀû°ú ¿¹Ãø
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ºÎ¹®º°
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º°
»ç¿ìµð¾Æ¶óºñ¾Æ
¾Æ¶ø¿¡¹Ì¸®Æ®
À̽º¶ó¿¤
³²¾ÆÇÁ¸®Ä«°øÈ±¹
±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Á¦10Àå 3D ÇÁ¸°Æ® ÀǾàǰ ±â¾÷ÀÇ °æÀï ±¸µµ
3D ÇÁ¸°Æ® ÀǾàǰ ½ÃÀåÀÇ °æÀï
ÆÄÆ®³Ê½Ê/Á¦ÈÞ/ÇÕÀÇ
ÇÕº´¡¤Àμö
½ÅÁ¦Ç° Ãâ½Ã
±âŸ °³¹ß
Á¦11Àå ±â¾÷ °³¿ä
»óÀ§ 10»çÀÇ Á¡À¯À² ºÐ¼®
½ÃÀå ÁýÁßµµ
Aprecia
Formac Pharmaceuticals
Extend Biosciences
Affinity Therapeutics
Osmotica Pharmaceuticals
GSK Group of Companies
FabRx Ltd.
Hewlett Packard Caribe
Merck & Co. Inc.
Cycle Pharmaceuticals
AstraZeneca.
KSA
¿µ¹® ¸ñÂ÷
¿µ¹®¸ñÂ÷
The global demand for 3D Printed Drugs Market is presumed to reach the market size of nearly USD 328.36 MN by 2030 from USD 77.27 MN in 2022 with a CAGR of 17.44% under the study period 2023 - 2030.
3D printed drugs are medications designed by 3D printing techniques to customize for individuals for more safety and effectiveness. 3D printed drugs have unitary porous structures that readily disperse in the mouth, as a result of which these high-dose medicines need not be swallowed intact.
MARKET DYNAMICS:
The increase in demand for instantaneous soluble drugs that can disperse easily in the mouth is one of the main factors that drive the growth of the global 3D printed drugs market. Moreover, an increase in the prevalence of dysphagia, a rise in usage of 3D printing techniques in the medical & healthcare industries, an increase in the adoption of personalized drugs, and the production of combination medicine boost the market growth. Furthermore, a rise in awareness about the advantages of the drugs, such as ease of intake of the drugs for the elderly, infants, and patients suffering from seizures-causing diseases such as epilepsy will ensure high demand under the projection period. Additionally, improvement in healthcare infrastructure and technological advancements in developing countries are the factors that are believed to influence the development of the 3D printed drugs market in upcoming years. However, the absence of government regulations related to 3D printed drugs and the harmful effects of 3D printed drugs may hamper the market growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of 3d printed drugs. The growth and trends of 3d printed drugs industry provide a holistic approach to this study.
MARKET SEGMENTATION:
This section of the 3d printed drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Technology
Inkjet Printing
Fused Deposition Modeling
Stereolithography
Zipdose Technology
By Application
Orthopedic
Neurology
Dental
Others
By End-Use
Hospitals & Clinics
Research Laboratories
Others
REGIONAL ANALYSIS:
This section covers the regional outlook, which accentuates current and future demand for the 3D Printed Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the 3d printed drugs market include Aprecia, Formac Pharmaceuticals, Extend Biosciences, Affinity Therapeutics, Osmotica Pharmaceuticals, GSK Group of Companies, FabRx Ltd., Hewlett Packard Caribe, Merck & Co. Inc., Cycle Pharmaceuticals, AstraZeneca. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.